AstraZeneca PLC (AZN): revenue growth, 5-year cagr, 10 filed years
Revenue CAGR 5y at AstraZeneca PLC was 17.1% in FY2025, the newest filed year. Across the 10 computed years from FY2016 it ranged from -7.3% (FY2016) to 17.3% (FY2024), with a median of 5.9%.
Tonight's figure on the company page: 17.1%, recomputed 2026-10-15. The table is each filed year on its own terms, with the formula below; the current figure may use trailing twelve months or, where the explainer says so, a different denominator.
Year by year
| Fiscal year | Revenue CAGR 5y | Read from |
|---|---|---|
| FY2016 | -7.3% | 20-F, filed 2018-03-06 |
| FY2017 | -4.3% | 20-F, filed 2018-03-06 |
| FY2018 | -3.1% | 20-F, filed 2019-03-05 |
| FY2019 | -1.7% | 20-F, filed 2020-03-03 |
| FY2020 | 1.5% | 20-F, filed 2021-02-16 |
| FY2021 | 10.2% | 20-F, filed 2022-02-22 |
| FY2022 | 14.6% | 20-F, filed 2023-02-21 |
| FY2023 | 15.7% | 20-F, filed 2024-02-20 |
| FY2024 | 17.3% | 20-F, filed 2025-02-18 |
| FY2025 | 17.1% | 20-F, filed 2026-02-24 |
How each year is computed
(Revenue this year / revenue five fiscal years earlier)^(1/5) - 1, x 100
Each year is a ratio of lines in that year's filed annual report, with the nightly recompute's own rules for what counts as a filed line. Nothing is estimated, smoothed or filled in: a year that cannot be computed says why.
Read further
A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.